Featured Research

from universities, journals, and other organizations

Health care-associated infections are exacerbated by alcohol use disorders, study finds

Date:
April 15, 2011
Source:
Alcoholism: Clinical & Experimental Research
Summary:
Health care-associated infections (HAIs) are infections that patients acquire during their hospitalization and that were not present at the time of admission to the hospital. A new study has found that people with alcohol use disorders who develop HAIs have longer hospital stays, thousands of dollars of higher hospital costs, and much greater odds of dying.

Hospital patients with alcohol use disorders (AUDs) are at an increased risk of developing healthcare-associated infections (HAIs), which affect 1.7 million patients annually in the United States. HAIs are infections that patients acquire during their hospitalization and that were not present at the time of admission to the hospital. A new study has found that people with AUDs who develop HAIs have longer hospital stays, thousands of dollars of higher hospital costs, and much greater odds of dying.

Results will be published in the July 2011 issue of Alcoholism: Clinical & Experimental Research and are currently available at Early View.

"Patients who are diagnosed with AUDs by their physicians have a 71 percent higher odds of dying from HAIs," said Marjolein de Wit, associate professor of medicine at Virginia Commonwealth University and first author of the study. "Pneumonia is one type of HAI we evaluated. Sepsis, an inflammatory state that is caused by any infection and that was not present at the time of hospital admission, was the second type of HAI examined."

de Wit and her colleagues both evaluated patients with HAIs and assessed their outcomes (mortality, hospital length of stay, hospital costs). They drew data from the Nationwide Inpatient Sample for the year 2007, and performed a retrospective study of all patients who developed healthcare-associated pneumonia or sepsis, while excluding patients who were transferred from another healthcare facility, and who were diagnosed with community-acquired infections, immunosuppression, or cancer.

"Patients with AUDs who develop HAIs had a 71 percent higher odds of dying, had a two-day longer hospital length of stay, and had approximately $7,500 higher hospital costs compared to patients without AUDs who develop HAIs," said de Wit.

"In addition, AUD patients with healthcare-associated pneumonia or sepsis were younger, had a lower income, had frequent emergencies, and experienced less surgery," said Claudia Spies, head of the department of anesthesiology and intensive care medicine at the University Hospital Charitι Universitaetsmedizin Berlin. "However, despite having fewer comorbidities, they died more often."

Spies added that she was very concerned to see more young people with HAIs coming to the hospital too late to be treated adequately. "These young patients with a low income usually do not see a physician unless they have been injured," she said. "If they come in, they come late and require immediate and intensive treatment. We have had similar discussions concerning young people with H1N1 in Europe."

"Much can be done to decrease the risk of developing HAIs," said de Wit. "'External' measures such as hand washing and head-of-bed elevation are important factors in decreasing the risk of HAIs, and can be undertaken by all healthcare providers. Conversely, and unlike external measures, AUDs are factors intrinsic to patients and thus preventing HAIs in patients with AUDs requires therapeutic interventions specifically targeting hospitalized patients with AUDs."

Both de Wit and Spies also said that it is very important for patients to discuss their alcohol consumption patterns with their physicians, despite the stigma they may feel.

"This is important both when a hospital admission is scheduled as well as at the time of an emergency hospital admission," said de Wit. "In the case with scheduled surgeries, such as an elective surgery, one month pre-operative abstinence may decrease the risk of HAIs."

"Follow-up care for patients with an AUD diagnosis is also important," said Spies. "Since these patients are often stigmatized due to their underlying AUD, they will need anonymous data handling as well as help to find adequate intervention and treatment for their AUD after their stay in the hospital, such as what is offered by physicians that can help them maintain their health."


Story Source:

The above story is based on materials provided by Alcoholism: Clinical & Experimental Research. Note: Materials may be edited for content and length.


Journal Reference:

  1. Marjolein de Wit, Marya D. Zilberberg, Jessica M. Boehmler, Gonzalo M. Bearman, Michael B. Edmond. Outcomes of Patients with Alcohol Use Disorders Experiencing Healthcare-Associated Infections. Alcoholism: Clinical and Experimental Research, 2011; DOI: 10.1111/j.1530-0277.2011.01475.x

Cite This Page:

Alcoholism: Clinical & Experimental Research. "Health care-associated infections are exacerbated by alcohol use disorders, study finds." ScienceDaily. ScienceDaily, 15 April 2011. <www.sciencedaily.com/releases/2011/04/110415163523.htm>.
Alcoholism: Clinical & Experimental Research. (2011, April 15). Health care-associated infections are exacerbated by alcohol use disorders, study finds. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/04/110415163523.htm
Alcoholism: Clinical & Experimental Research. "Health care-associated infections are exacerbated by alcohol use disorders, study finds." ScienceDaily. www.sciencedaily.com/releases/2011/04/110415163523.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins